TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
Supplemental materials for: Ma et al
Files in this Data Supplement:
Document 1. Supplemental methods, figures, and table (PDF, 2 MB)